GLOME Holdings (8938) · RiskReframed
Risk of higher costs for alliance medical institutions due to the increase in the consumption tax rate to 10%
First written in FY2020-Q1. 1 of 2 entries say "Reframed", first in FY2020-Q2. Latest entry: FY2020-Q2.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Earnings impact on the dispensing business from consumption tax rate changes and differences in drug price pass-throughA theme 10 companies write about · 10 as a headwind · 0 as a tailwind
0 other companies' latest entry also says "Reframed".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2020-Q2ReframedAnnual report
「As a result, the increase in the consumption tax rate to 10% implemented in October this year could result in further cost increases under the current tax system and affect the operating performance of the alliance medical institutions of our group.」
Although the increase in the consumption tax rate to 10% changed from a planned measure to an implemented measure, its impact on alliance medical institutions continues to be described as a possibility. - FY2020-Q1First statedAnnual report
「As a result, the planned increase in the consumption tax rate to 10% in October this year could result in further cost increases under the current tax system and affect the operating performance of the alliance medical institutions of our group.」
Against the backdrop of medical services being tax-exempt while medical institutions bear consumption tax on their purchases, the risk that the scheduled increase in the tax rate to 10% in October 2019 could affect alliance medical institutions and alliance businesses was described for the first time.